Early Warning Press Release in Accordance With National Instrument 62-103
Early Warning Press Release in Accordance With National Instrument 62-103
Vancouver, British Columbia--(Newsfile Corp. - April 4, 2024) - Cathay Visions Enterprises Ltd. (the "Acquiror") acquired 110,000 common shares (each a "Common Share") of Optimi Health Corp. (the "Issuer") pursuant to acquisitions in the public market. The Common Shares of the Issuer are listed on the CSE under the trading symbol "OPTI".
不列颠哥伦比亚省温哥华--(Newsfile Corp.,2024 年 4 月 4 日)-国泰愿景企业有限公司(”收购者“) 收购了 110,000 股普通股(每股 a)”常见 分享“) 的 Optimi Health Corp.(”发行人“)根据公开市场的收购。发行人的普通股在CSE上市,交易代码为 “OPTI”。
Prior to giving effect to the foregoing acquisition of Common Shares, the Acquiror owned and/or had control over an aggregate of 8,875,483 Common Shares, representing approximately 9.96% of the issued and outstanding Common Shares of the Issuer on an undiluted basis. Following completion of the acquisition of the Common Shares, the Acquiror owns or has control or direction over, directly or indirectly, 8,985,483 Common Shares, 166,666 warrants, 450,000 stock options and 15,750 restricted share rights, representing approximately 10.09% of the issued and outstanding Common Shares of the Issuer on an undiluted basis and approximately 10.72% of the total issued and outstanding Common Shares of the Issuer on a partially diluted basis.
在上述普通股收购生效之前,收购方共拥有和/或控制了8,875,483股普通股,约占发行人未稀释已发行和流通普通股的9.96%。普通股收购完成后,收购方直接或间接拥有或控制或指导8,985,483股普通股、166,666份认股权证、45万股股票期权和15,750股限制性股权,约占发行人未稀释已发行和流通普通股的10.09%,部分摊薄后占发行人已发行和流通普通股总额的10.72% 基础。
The Acquiror may acquire additional securities or dispose of securities of the Issuer in the future either on the open market, privately or otherwise depending on market conditions, reformulation of plans, other available investment business opportunities and/or other relevant factors.
根据市场状况、计划的重新制定、其他可用的投资商业机会和/或其他相关因素,收购方将来可以在公开市场上、私下或其他方式收购更多证券或处置发行人的证券。
For further information or to receive a copy of the early warning report filed by the Acquiror with securities regulatory authorities in Canada in connection with this press release, please contact Leah Hodges at (604) 377-0403 or refer to the Issuer's SEDAR+ profile at .
欲了解更多信息或获取收购方就本新闻稿向加拿大证券监管机构提交的预警报告的副本,请致电 (604) 377-0403 与 Leah Hodges 联系,或参阅发行人的SEDAR+简介,网址为。